Speaker illustration

Doctor Ioannis Lianos

251 Air Force General Hospital, Athens (Greece)

A randomized, pharmacodynamic comparison of low dose ticagrelor (60mg bid) to low dose prasugrel (5mg od) in patients with prior myocardial infarction: the ALTIC-2 study

Event: ESC CONGRESS 2019

Topic: Antiplatelet Drugs

Session: Antiplatelet therapy


This platform is supported by

logo Novo Nordisk